MLchartDataset catalogue

A6

Term · Oncology and biomedicine · MLC-T-ONC-000087

A substance being studied in the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called urokinase plasminogen activator (uPA)-derived peptide A6.

Table 1. Record
IdentifierMLC-T-ONC-000087
FieldOncology and biomedicine
Synonymsurokinase plasminogen activator (uPA)-derived peptide A6
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000087",
  "term": "A6",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called urokinase plasminogen activator (uPA)-derived peptide A6.",
  "synonyms": [
    "urokinase plasminogen activator (uPA)-derived peptide A6"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/a6/"
}

Record 145 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.